MedPath

Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section

Not Applicable
Recruiting
Conditions
Cesarean Section
Local Anesthetic
Interventions
Registration Number
NCT06376058
Lead Sponsor
Aretaieion University Hospital
Brief Summary

This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean sections

Detailed Description

Neuraxial techniques are the anesthetic techniques of choice in contemporary obstetric anesthesia practice, with a definitive superiority as compared to general anesthesia, since, by their use, serious complications involving the airway can be avoided. Combined spinal-epidural anesthesia has become the favorable technique for both elective and emergency cesarean sections. Various local anesthetics have been used, but ropivacaine is the drug of choice in most hospitals in Greece. However, chloroprocaine is a preferable local anesthetic in USA due to its quick and predictable onset of action. Chloroprocaine was initially used in 1980, but it became obsolete in those years due to neurological symptoms associated with its use caused mainly by the presence of sodium bisulfite and disodium ethylenediaminetetraacetate (EDTA) in the early formulations. Nowadays, new formulations of the drug without EDTA makes chloroprocaine safe for use.

The aim of the current randomized controlled trial will be to compare the effect of an intrathecal fixed dose of chloroprocaine versus an intrathecal fixed dose of ropivacaine in parturients subjected to elective cesarean section under combined spinal-epidural anesthesia.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • adult parturients, American Society of Anesthesiologists (ASA) I-II,
  • singleton gestation>37 weeks
  • elective cesarean section
Exclusion Criteria
  • American Society of Anesthesiologists (ASA) > III
  • age < 18 years
  • singleton gestation <37 weeks
  • Body Mass Index (BMI) >40 kg/m2
  • Body weight <50 kg
  • Body weight>100 kg
  • height<150 cm
  • height>180 cm
  • multiple gestation
  • emergency delivery
  • fetal abnormality
  • fetal distress
  • pregnancy-induced pathology such as preeclampsia, eclampsia, premature labor, placental abnormalities
  • pregnancy- induced diseases such as hepatic failure, pseudocholinesterase deficiency, neuromuscular diseases
  • lack of informed consent
  • contraindication for regional anesthesia such as thrombocytopenia, coagulation abnormalities, allergy to local anesthetics

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ropivacaine groupRopivacaine 0.75% Injectable Solutionintrathecal fixed dose of ropivacaine 0.75%
chloroprocaine groupChloroprocaine 1% Injectable Solutionintrathecal fixed dose of chloroprocaine 1%
Primary Outcome Measures
NameTimeMethod
duration of staying in PACU2 hours postoperatively

duration of parturient stay in PACU

level of sensory block every 15 minintraoperative

measurement of sensory block every 15 minutes from spinal anesthesia to the end of the surgery

pain at neonatal deliveryintraoperative

pain at neonatal delivery using VAS scale, where VAS=0, no pain; VAS=10, worst pain imaginable

pain at peritoneal manipulationintraoperative

pain at peritoneal manipulation using VAS scale, where VAS=0, no pain; VAS=10, worst pain imaginable

pain at Post Anesthesia Care Unit (PACU) discharge1 hour postoperatively

pain at Post Anesthesia Care Unit (PACU) discharge using VAS scale, where VAS=0, no pain; VAS=10, worst pain imaginable

Time from spinal anesthesia to T10 block (min)intraoperative

time required from spinal anesthetic injection to anesthetic block up to the 10th thoracic neurotome

Time from spinal anesthesia to T4 block (min)intraoperative

time required from spinal anesthetic injection to anesthetic block up to the 4th thoracic neurotome

Time of spinal anesthesia to Bromage =3intraoperative

time required from spinal anesthetic injection to complete motor block (Bromage scale=3, where Bromage=0, no block; Bromage=1, partial block; Bromage=2, almost complete block; Bromage=3, complete block

level of sensory block every 3 minintraoperative

measurement of sensory block every 3 minutes after spinal anesthesia during the first 15 minutes

highest level of sensory blockintraoperative

measurement of the highest level of sensory block after intrathecal infusion of local anesthetic

time from spinal anesthesia to highest level of sensory blockintraoperative

time from the performance of spinal anesthesia to the highest level of sensory block

duration of sensory blockintraoperative

measurement of time required for the sensory block to regress from sensory level T4 to sensory level T12/L2

pain at surgical incisionintraoperative

pain at skin incision using Visual Analogue Scale (VAS), where VAS=0, no pain; VAS=10, worst pain imaginable

pain at Post Anesthesia Care Unit (PACU) admission1 hour postoperatively

pain at Post Anesthesia Care Unit (PACU) admission using VAS scale, where VAS=0, no pain; VAS=10, worst pain imaginable

need for rescue analgesia intraoperativelyintraoperative

need for rescue analgesia during the operation, via epidural catheter or intravenously

Bromage scale every 3 min after spinal anesthesiaintraoperative

measurement of bromage scale every 3 minutes after spinal anesthesia during the first 15 minutes

Bromage scale every 15 minintraoperative

measurement of bromage scale every 15 minutes from spinal anesthesia to the end of the surgery

duration of motor block1 hour postoperatively

measurement of time required for bromage scale to regress from 3 to 0

Secondary Outcome Measures
NameTimeMethod
need for atropineintraoperative

any need for atropine during the operation because of bradycardia will be recorded

incidence of drowsinessintraoperative

any occurence of drowsiness during the operation will be recorded

incidence of discomfortintraoperative

any occurence of discomfort during the operation will be recorded

neonatal blood gases1 minute post delivery

fetal cord blood analysis will be performed immediately post-delivery

need for vasoconstrictorintraoperative

any need for vasoconstrictor during the operation will be recorded

time from spinal anesthesia to rescue analgesia in PACU2 hours postoperatively

time from spinal anesthesia to rescue analgesia in PACU will be recorded

Neonatal Apgar score at 5 minutes1 minute post delivery

Neonatal Apgar score will be recorded at 5 minutes after delivery. The Apgar score is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. Scores 7 and above are generally normal; 4 to 6, fairly low; and 3 and below are generally regarded as critically low and cause for immediate resuscitative efforts

Neonatal Apgar score at 1 minute1 minute post delivery

Neonatal Apgar score will be recorded at 1 minute after delivery. The Apgar score is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. Scores 7 and above are generally normal; 4 to 6, fairly low; and 3 and below are generally regarded as critically low and cause for immediate resuscitative efforts

incidence of neonatal acidosis1 minute post delivery

incidence of neonatal acidosis (PH\<7.2) will be recorded

incidence of hypotensionintraoperative

any occurence of hypotension (systolic blood pressure\<80% of baseline) throughout the operation will be recorded

incidence of bradycardiaintraoperative

any incidence of maternal bradycardia (heart rate\<60/min) will be recorded

incidence of dizzinessintraoperative

any occurence of dizziness during the operation will be recorded

incidence of nausea/vomitingintraoperative

any occurence of nausea and/or vomiting during the operation will be recorded

incidence of shiveringintraoperative

any occurence of shivering during the operation will be recorded

need for rescue analgesia in PACU2 hours postoperatively

need for rescue analgesia in PACU when VAS scale \>4 will be recorded

incidence of neurological symptoms during hospital stay5 days postoperatively

incidence of neurological symptoms during hospitalization will be recorded

incidence of low back pain2 months after discharge

incidence of low back pain 2 months after discharge from the hospital will be recorded by phone communication

time from spinal anesthesia to mobilization2 days postoperatively

time from spinal anesthesia to mobilization of parturient will be recorded

mother's satisfaction from anesthesia1 day postoperatively

mother's satisfaction from anesthesia will be recorded using Likert scale. Likert scale ranges from 1 which is the minimum satisfaction to 4 which is the maximum satisfaction

gynecologist's satisfaction1 hour postoperatively

gynecologist's satisfaction from anesthesia will be recorded using Likert scale. Likert scale ranges from 1 which is the minimum satisfaction to 4 which is the maximum satisfaction

incidence of neurological symptoms 2 months after the operation2 months after discharge

incidence of neurological symptoms 2 months after discharge from the hospital will be recorded by phone communication

Trial Locations

Locations (1)

Aretaieion University Hospital

🇬🇷

Athens, Greece

© Copyright 2025. All Rights Reserved by MedPath